Selected publications
鈥淎ngiotensin blockade therapy and survival in pancreatic cancer: a population study鈥
Keith SW, Maio V, Arafat HA, Alcusky M, Karagiannis T, Rabinowitz C, Lavu H, Louis DZ
BMC Cancer. 2022 Feb 7;22(1):150. doi: 10.1186/s12885-022-09200-4. PMID: 35130875; PMCID: PMC8819908
鈥淗ypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations鈥
Sarosiek K, Gandhi AV, Saxena S, Kang CY, Chipitsyna GI, Yeo CJ, Arafat HA
J Thyroid Res. 2016;2016:2454989. doi: 10.1155/2016/2454989. Epub 2016 Mar 31. PubMed PMID: 27123358; PubMed Central PMCID: PMC4830736
鈥淗ypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion, Preliminary Observations鈥
Sarosiek K, Ankit V. Gandhi AV, Saxena S, Kang CY, Chipitsyna GI, Yeo C, Arafat HA
J. Thyroid Res, 2016, Article ID 2454989
鈥淎ngiotensin type 2 receptor: A novel modulator of inflammation in pancreatic ductal adenocarconima through Regulation of NFkB activity鈥
Gandhi A, Chipitsyna G, Relles D, Yeo CJ, Arafat HA
J. Cancer Tum International, 2017. 5(1) 1-11
鈥淭hymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation鈥
Relles D, Chipitsyna GI, Gong Q, Yeo CJ, Arafat HA
Adv Prev Med. 2016;2016:1407840. doi: 10.1155/2016/1407840. Epub 2016 Dec 26. PubMed PMID: 28105374; PubMed Central PMCID: PMC5220391
鈥淐onserved Metabolic Changes in Nondiabetic and Type 2 Diabetic Bariatric Surgery Patients: Global Metabolomic Pilot Study鈥
Sarosiek K, Pappan KL, Ankit V. Gandhi AV, Saxena S, Christopher Y. Kang CY, McMahon H, Chipitsyna GI, Tichansky DS, Arafat HA
J. Diabetes Res, 2016 (2016), Article ID 3467403
鈥淥steopotntin (OPN) isoforms in cancer diabetes and obesity, what鈥檚 one got to do with the other?鈥
Sarosiek K, Kang C, AlZoubi M, Chipitsyna G, Saxena S, Gandhi A, Yeo CJ, Arafat HA
J Gastrointest Surg. 2015 Apr;19(4):639-50
鈥淗eme oxygenase-1 gene promoter polymorphism is associated with the development of necrotizing acute pancreatitis鈥
Gulla A, Evans BJ, Navenot JM, Pundzius J, Barauskas G, Gulbinas A, Dambrauskas Z, Arafat H, Wang ZX
Pancreas. 2014 Nov;43(8):1271-6
鈥淥steopontin Isoform OPNc: a Potential Marker of Metastasis in Pancreatic Ductal Adenocarcinoma鈥
Siddiqui A, Jones E, Lazar M+, Salem K, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA
J Gastroenterol Hepatol. 2014 Jun;29(6):1321-7
鈥淐linical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma鈥
Kang CY, Wang J, Axell-House D, Soni P, Chu ML, Chipitsyna G, Sarosiek K, Sendecki J, Hyslop T, Al-Zoubi M, Yeo CJ, Arafat HA
J Gastrointest Surg. 2013 Sep 4. [Epub ahead of print] PubMed PMID: 24002763